Loading...

Anupam Kumar, PhD

Title(s)Postdoctoral Scholar, Neurological Surgery
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    All India Institutes of Medical Science (AIIMS), Delhi,IndiaPhDBrain tumour
    VIT University, Vellore, IndiaMSBiomedical Genetics

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Kumar A, Nayak S, Pathak P, Purkait S, Malgulawar PB, Sharma MC, Suri V, Mukhopadhyay A, Suri A, Sarkar C. Identification of miR-379/miR-656 (C14MC) cluster downregulation and associated epigenetic and transcription regulatory mechanism in oligodendrogliomas. J Neurooncol. 2018 Jun 21. PMID: 29931616.
      View in: PubMed
    2. Nayak S, Aich M, Kumar A, Sengupta S, Bajad P, Dhapola P, Paul D, Narta K, Purkrait S, Mehani B, Suri A, Chakraborty D, Mukhopadhyay A, Sarkar C. Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma. Sci Rep. 2018 May 16; 8(1):7673. PMID: 29769662.
      View in: PubMed
    3. Pal J, Patil V, Kumar A, Kaur K, Sarkar C, Somasundaram K. Loss-of-Function Mutations in Calcitonin Receptor (CALCR) Identify Highly Aggressive Glioblastoma with Poor Outcome. Clin Cancer Res. 2018 Mar 15; 24(6):1448-1458. PMID: 29263181.
      View in: PubMed
    4. Sarkar C, Chowdhuri AR, Kumar A, Laha D, Garai S, Chakraborty J, Sahu SK. One pot synthesis of carbon dots decorated carboxymethyl cellulose- hydroxyapatite nanocomposite for drug delivery, tissue engineering and Fe3+ ion sensing. Carbohydr Polym. 2018 Feb 01; 181:710-718. PMID: 29254027.
      View in: PubMed
    5. Ahmad F, Patrick S, Sheikh T, Sharma V, Pathak P, Malgulwar PB, Kumar A, Joshi SD, Sarkar C, Sen E. Telomerase reverse transcriptase (TERT) - enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma. J Neurochem. 2017 Dec; 143(6):671-683. PMID: 28833137.
      View in: PubMed
    6. Battu S, Kumar A, Pathak P, Purkait S, Dhawan L, Sharma MC, Suri A, Singh M, Sarkar C, Suri V. Clinicopathological and molecular characteristics of pediatric meningiomas. Neuropathology. 2018 Feb; 38(1):22-33. PMID: 28901666.
      View in: PubMed
    7. Kakkar A, Majumdar A, Pathak P, Kumar A, Kumari K, Tripathi M, Sharma MC, Suri V, Tandon V, Chandra SP, Sarkar C. BRAF gene alterations and enhanced mammalian target of rapamycin signaling in gangliogliomas. Neurol India. 2017 Sep-Oct; 65(5):1076-1082. PMID: 28879901.
      View in: PubMed
    8. Pathak P, Kumar A, Jha P, Purkait S, Faruq M, Suri A, Suri V, Sharma MC, Sarkar C. Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma. Brain Pathol. 2017 Sep; 27(5):580-589. PMID: 27608415.
      View in: PubMed
    9. Kaur K, Kakkar A, Kumar A, Purkait S, Mallick S, Suri V, Sharma MC, Julka PK, Gupta D, Suri A, Sarkar C. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas. J Neurooncol. 2016 12; 130(3):423-430. PMID: 27576698.
      View in: PubMed
    10. Kakkar A, Majumdar A, Kumar A, Tripathi M, Pathak P, Sharma MC, Suri V, Tandon V, Chandra SP, Sarkar C. Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs). Epilepsy Res. 2016 11; 127:141-151. PMID: 27599148.
      View in: PubMed
    11. Purkait S, Mallick S, Sharma V, Kumar A, Pathak P, Jha P, Biswas A, Julka PK, Gupta D, Suri A, Datt Upadhyay A, Suri V, Sharma MC, Sarkar C. Prognostic Stratification of GBMs Using Combinatorial Assessment of IDH1 Mutation, MGMT Promoter Methylation, and TERT Mutation Status: Experience from a Tertiary Care Center in India. Transl Oncol. 2016 Aug; 9(4):371-6. PMID: 27567961.
      View in: PubMed
    12. Kakkar A, Nambirajan A, Kaur K, Kumar A, Mallick S, Suri V, Sarkar C, Kale SS, Garg A, Sharma MC. ATRX loss in glioneuronal tumors with neuropil-like islands indicates similarity to diffuse astrocytic tumors. J Neurooncol. 2016 10; 130(1):63-68. PMID: 27469217.
      View in: PubMed
    13. Purkait S, Miller CA, Kumar A, Sharma V, Pathak P, Jha P, Sharma MC, Suri V, Suri A, Sharma BS, Fulton RS, Kale SS, Dahiya S, Sarkar C. ATRX in Diffuse Gliomas With its Mosaic/Heterogeneous Expression in a Subset. Brain Pathol. 2017 03; 27(2):138-145. PMID: 26833422.
      View in: PubMed
    14. Ahmad F, Dixit D, Sharma V, Kumar A, Joshi SD, Sarkar C, Sen E. Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma. Cell Death Dis. 2016 05 05; 7:e2213. PMID: 27148686.
      View in: PubMed
    15. Purkait S, Sharma V, Kumar A, Pathak P, Mallick S, Jha P, Sharma MC, Suri V, Julka PK, Suri A, Sharma BS, Sarkar C. Expression of DNA methyltransferases 1 and 3B correlates with EZH2 and this 3-marker epigenetic signature predicts outcome in glioblastomas. Exp Mol Pathol. 2016 Apr; 100(2):312-20. PMID: 26892683.
      View in: PubMed
    16. Purkait S, Mallick S, Sharma V, Kumar A, Pathak P, Jha P, Biswas A, Julka PK, Gupta D, Suri A, Upadhyay AD, Suri V, Sharma MC, Sarkar C. A simplified approach for molecular classification of glioblastomas (GBMs): experience from a tertiary care center in India. Brain Tumor Pathol. 2016 Jul; 33(3):183-90. PMID: 26865311.
      View in: PubMed
    17. Sharma V, Purkait S, Takkar S, Malgulwar PB, Kumar A, Pathak P, Suri V, Sharma MC, Suri A, Kale SS, Kulshreshtha R, Sarkar C. Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors. Brain Tumor Pathol. 2016 Apr; 33(2):117-28. PMID: 26746204.
      View in: PubMed
    18. Kakkar A, Kumar A, Das A, Pathak P, Sharma MC, Singh M, Suri A, Sarkar C, Suri V. 1p/14q co-deletion: A determinant of recurrence in histologically benign meningiomas. Indian J Pathol Microbiol. 2015 Oct-Dec; 58(4):433-8. PMID: 26549062.
      View in: PubMed
    19. Kaur K, Kakkar A, Kumar A, Mallick S, Julka PK, Gupta D, Suri A, Suri V, Sharma MC, Sarkar C. Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach. Brain Pathol. 2016 05; 26(3):334-43. PMID: 26222673.
      View in: PubMed
    20. Jha P, Agrawal R, Pathak P, Kumar A, Purkait S, Mallik S, Suri V, Chand Sharma M, Gupta D, Suri A, Sharma BS, Julka PK, Kulshreshtha R, Sarkar C. Genome-wide small noncoding RNA profiling of pediatric high-grade gliomas reveals deregulation of several miRNAs, identifies downregulation of snoRNA cluster HBII-52 and delineates H3F3A and TP53 mutant-specific miRNAs and snoRNAs. Int J Cancer. 2015 Nov 15; 137(10):2343-53. PMID: 25994230.
      View in: PubMed
    21. Mallick S, Gandhi AK, Joshi NP, Kumar A, Puri T, Sharma DN, Haresh KP, Gupta S, Julka PK, Rath GK, Sarkar C. Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors. Indian J Med Paediatr Oncol. 2015 Apr-Jun; 36(2):99-104. PMID: 26157286.
      View in: PubMed
    22. Kumar S, Kakkar A, Suri V, Kumar A, Bhagat U, Sharma MC, Singh M, Suri A, Sarkar C. Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of aggressive behavior. Neurol India. 2014 Jul-Aug; 62(4):376-82. PMID: 25237942.
      View in: PubMed
    23. Kakkar A, Kumar A, Jha P, Goyal N, Mallick S, Sharma MC, Suri A, Singh M, Kale SS, Julka PK, Sarkar C, Suri V. Meningeal hemangiopericytomas: a clinicopathological study with emphasis on MGMT (O(6) -methylguanine-DNA methyltransferase) promoter methylation status. Neuropathology. 2014 Aug; 34(4):333-42. PMID: 24521400.
      View in: PubMed